상세 보기
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- Choo, Eun Ju;
- Chambers, Henry F.
Citations
WEB OF SCIENCE
130Citations
SCOPUS
151초록
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
키워드
Methicillin-resistant Staphylcoccus aureus; Vancomycin; Treatment; MINIMUM INHIBITORY CONCENTRATION; BLOOD-STREAM INFECTIONS; RANDOMIZED PHASE-2 TRIAL; SALVAGE THERAPY; CLINICAL-EFFICACY; STANDARD THERAPY; RABBIT MODEL; VANCOMYCIN; DAPTOMYCIN; CEFTAROLINE
- 제목
- Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- 저자
- Choo, Eun Ju; Chambers, Henry F.
- 발행일
- 2016-12
- 유형
- Review
- 권
- 48
- 호
- 4
- 페이지
- 267 ~ 273
- 언어
- ENG
- 출판사
- Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy
- 발행국가
- 대한민국
- 분량
- 7 페이지
- ISSN
- E 2092-6448
P 2093-2340